This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Beardmore, W. B. Articles by Hebeka, E. K. Search for Related Content PubMed Articles by Beardmore, W. B. Articles by Hebeka, E. K. Agricola Articles by Beardmore, W. B. Articles by Hebeka, E. K.

 Previous Article  |  Next Article 

Appl Environ Microbiol. 1968 April; 16(4): 563-568
Copyright © 1968 American Society for Microbiology. All Rights Reserved.

Induction of an Inhibitor of Influenza Virus Hemagglutination by Treatment of Serum with Periodate

Research Laboratories, Parke, Davis & Co., Detroit, Michigan 48232

ABSTRACT

Serum is commonly treated with potassium periodate to destroy nonspecific inhibitors of influenza virus hemagglutination. We have observed, however, that such treatment of serum without pre-existing inhibitor produced high titers of inhibitor against certain strains of influenza virus. Inhibitor was induced in the serum from several different animal species but not in hamster or mouse serum. Periodate treatment of serum albumin, fraction V, from several animals, including man, creates this inhibitor. Our data indicate that the inhibitor induced in the serum of various animal species differs in its mechanism of induction and in its resistance to receptor-destroying enzyme and trypsin. Hemagglutination by B/Singapore/3/64, B/Colorado/2/65, B/Georgia/1/65, and B/Massachusetts/3/66 strains of influenza virus is inhibited by periodate-treated human serum at dilutions as high as 1:5,120. The routine use of periodate treatment of serum in diagnostic and surveillance studies of influenza virus infections is not recommended.